Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.
Checked against the public recordLast updated Feb 6, 2020 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Interventions being studied
- Other: Survey
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * All participants must be 18 years of age or older. * Patient participants must have Stage III, IV and/or recurrent NSCLC. * Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change * Patients must have working email address and internet access Exclusion Criteria: * Any participant who cannot understand written or spoken English. * Any participant who is not competent to provide informed consent for study participation per the investigator. * Any participant who cannot be present for the related study visits and/or complete the post-test assessment
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 6, 2020. Always confirm current availability with the study team.